The prognosis is impaired in NAFLD patients with diabetes despite negative FIB4 <1.30

被引：0
|
作者：
Boursier, Jerome [1 ]
Ekstedt, Mattias [2 ]
Gomez, Manuel Romero [3 ]
Moreau, Clemence [4 ]
Bonacci, Martin [5 ]
Cure, Sandrine [5 ]
Trylesinski, Aldo [5 ]
Hagstrom, Hannes [6 ]
机构：
[1] Angers Univ Hosp, Angers, France
[2] Linkoping Univ, Linkoping, Sweden
[3] Univ Seville, Seville, Spain
[4] Angers Univ, Angers, France
[5] Intercept, London, North Ireland
[6] Karolinska Inst, Stockholm, Sweden
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-313
引用
收藏
页码：S557 / S558
页数：2
相关论文
共 50 条
  • [31] FIB-4 index to rule-out advanced liver fibrosis in NAFLD patients
    Mallet, Vincent
    Parlati, Lucia
    Vallet-Pichard, Anais
    Terris, Benoit
    Tsochatzis, Emmanuel
    Sogni, Philippe
    Pol, Stanislas
    PRESSE MEDICALE, 2019, 48 (12): : 1484 - 1488
  • [32] The likelihood ratios of FIB-4-values for diagnosing advanced liver fibrosis in patients with NAFLD
    Asberg, Arne
    Lofblad, Lena
    Hov, Gunhild Garmo
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2023, 61 (11) : E233 - E234
  • [33] Use of FIB4 as a screening test in the bariatric population instead of the NAFLD fibrosis score reduces referral rate to hepatology without reducing identification of significant fibrosis: a retrospective audit
    Carbonell, Michael
    Lennie, Craig
    Davison, Nuala
    Gomez, Naim Fakih
    Greener, Veronica
    Abeles, R. Daniel
    JOURNAL OF HEPATOLOGY, 2024, 80 : S553 - S553
  • [34] LONGITUDINAL CHANGE IN FIB4 SCORE IN PATIENTS WITH DIABETES MELLITUS TREATED WITH GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST OR SODIUM/GLUCOSE COTRANSPORTER 2 INHIBITORS
    Moriya, Akio
    Inoue, Kentaro
    Mashima, Soichiro
    Matsumoto, Saytaka
    Yoshida, Yasunari
    Iwasaki, Yoshiaki
    Ando, Masaharu
    GASTROENTEROLOGY, 2019, 156 (06) : S1298 - S1298
  • [35] Predictive value of APRI and FIB4 scores for liver fibrosis assessment in comparison to Transient Elastography in chronic hepatitis C patients
    Matta, Bassem
    Wilder, Julius M.
    Lee, Tzu-Hao
    Patel, Keyur
    HEPATOLOGY, 2015, 62 : 1129A - 1130A
  • [36] Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection
    Bruno, Raffaele
    Sacchi, Paolo
    Cima, Serena
    Maiocchi, Laura
    Patruno, Savino F. A.
    Klersy, Catherine
    Barbarini, Giorgio
    Zuccaro, Valentina
    Camma, Calogero
    Filice, Gaetano
    DIGESTIVE AND LIVER DISEASE, 2011, 43 (07) : 575 - 578
  • [37] The Impact of Increased Fib-4 Score in Patients with Type II Diabetes Mellitus on COVID-19 Disease Prognosis
    Calapod, Ovidiu P.
    Marin, Andreea M.
    Onisai, Minodora
    Tribus, Laura C.
    Pop, Corina S.
    Fierbinteanu-Braticevici, Carmen
    MEDICINA-LITHUANIA, 2021, 57 (05):
  • [38] Letter: should we abandon FIB-4 to characterise noninvasively patients with NAFLD? Authors′ reply
    Henry, Linda
    Younossi, Zobair
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (08) : 922 - 923
  • [39] Non-invasive detection of NASH and significant fibrosis in NAFLD patients with low FIB-4
    Liebig, Stephanie
    Hohenester, Simon
    Manns, Michael P.
    Bantel, Heike
    JOURNAL OF HEPATOLOGY, 2020, 73 : S403 - S403
  • [40] Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4
    John, Katharina
    Franck, Martin
    Al Aoua, Sherin
    Rau, Monika
    Huber, Yvonne
    Schattenberg, Joern M.
    Geier, Andreas
    Bahr, Matthias J.
    Wedemeyer, Heiner
    Schulze-Osthoff, Klaus
    Bantel, Heike
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
12345